{
  "timestamp": "2025-12-16T11:51:28.862719",
  "data": {
    "trials": {
      "summary": {
        "active": 4,
        "completed": 1,
        "phase_distribution": {
          "Observational": 1,
          "Phase 1": 0,
          "Phase 2": 3,
          "Phase 3": 0,
          "Phase 4": 1
        }
      },
      "details": [
        {
          "trial_id": "NCT04854837",
          "title": "Safety of Remdesivir Treatment in COVID-19 Patients Requiring Hemodialysis",
          "status": "Completed",
          "phase": "Observational",
          "sponsor": "Semmelweis University",
          "locations": [
            "Hungary"
          ],
          "start_date": "2021-04-12",
          "end_date": "2022-09-30"
        },
        {
          "trial_id": "NCT04386447",
          "title": "Phase II, Multicenter, Open-label, Rct With an Adaptive Design, to Assess Efficacy of Intravenous Administration of Oxytocin in Hospitalized Patients Affected by COVID-19",
          "status": "Active",
          "phase": "Phase 2",
          "sponsor": "Azienda Ospedaliero-Universitaria di Parma",
          "locations": [
            "Italy",
            "France"
          ],
          "start_date": "2020-09-01",
          "end_date": "2020-12-31"
        },
        {
          "trial_id": "NCT04403477",
          "title": "Convalescent Plasma Transfusion Therapy in Severe COVID-19 Patients- a Tolerability, Efficacy and Dose-response Phase II RCT",
          "status": "Active",
          "phase": "Phase 2",
          "sponsor": "Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh",
          "locations": [
            "Bangladesh"
          ],
          "start_date": "2020-05-20",
          "end_date": "2020-10-30"
        },
        {
          "trial_id": "NCT04321993",
          "title": "Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients",
          "status": "Active",
          "phase": "Phase 2",
          "sponsor": "Lisa Barrett",
          "locations": [
            "Canada"
          ],
          "start_date": "2020-04-17",
          "end_date": "2024-04"
        },
        {
          "trial_id": "NCT06792214",
          "title": "Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD (DEFEND) Clinical Trial",
          "status": "Active",
          "phase": "Phase 4",
          "sponsor": "Mount Sinai Hospital, Canada",
          "locations": [
            "Canada"
          ],
          "start_date": "2025-01-03",
          "end_date": "2027-01"
        }
      ],
      "notes": "Parsed deterministically from ClinicalTrials.gov"
    }
  }
}